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SocietyOn December 5 and 6, 2002, OMERACT (Outcome Mea-
sures in Rheumatology Clinical Trials) and OARSI (Osteo-
arthritis Research Society International), with support from
various pharmaceutical companies listed at the beginning
of this supplement, held a Workshop for Consensus on
Osteoarthritis Imaging in Bethesda, MD. The Workshop in-
cluded participants from the academic, pharmaceutical
and regulatory communities from US, Europe and Aus-
tralia. The aim of the Workshop was to provide a state
of the art review of imaging outcome measures for osteo-
arthritis of the knee to help guide scientists and pharma-
ceutical companies in conducting longitudinal, multi-site
studies of this disease. A speciﬁc goal was to recommend
robust techniques for acquiring radiographs and magnetic
resonance images (MRI) of the knee for the Osteoarthritis
Initiative (web site), a 5000-subject, 5-year observational
study aimed at understanding the structural determinants
of clinical outcomes in osteoarthritis and identifyingA1biomarkers applicable to clinical trials of potential thera-
pies for this disease. Another goal of the Workshop was
to identify techniques that could be used in studies of
less than 1-year duration e for so-called ‘‘Proof of
Concept’’.
The following reports summarize the results of these dis-
cussions and are organized in two sections. The ﬁrst sec-
tion addresses applications of MRI for quantifying articular
cartilage in the knee and evaluating the joint as a whole
organ. The second section focuses on radiographic tech-
niques for monitoring structural progression in osteoarthritis.
While it is true that advances have been made in both of
these areas since the Workshop was originally held in
2002, the pace of this progress has been slow. It is hoped,
therefore, that by publishing this information, research in this
area will be accelerated and the ﬁeld will move more rapidly
towards a deeper understanding of this enigmatic disease
and potential ways of treating it.a Dr. Woodworth no longer works at Pﬁzer.
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